<DOC>
	<DOCNO>NCT01789567</DOCNO>
	<brief_summary>To confirm safety performance Medtronic Engager™ Transcatheter Aortic Valve Implantation System via direct aortic approach .</brief_summary>
	<brief_title>Engager Direct Aortic Clinical Study</brief_title>
	<detailed_description>To confirm safety performance Medtronic Engager™ Transcatheter Aortic Valve Implantation System via direct aortic approach patient symptomatic severe aortic valve stenosis high extreme risk surgical aortic valve replacement treatment via direct aortic access prefer .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Severe aortic stenosis define Doppler echocardiography : aortic valve area ≤ 0.8 cm2 ( AVA index ≤ 0.5 cm2/m2 ) , mean gradient ≥ 40 mmHg , max velocity ≥ 4m/s NYHA Functional Class II great ; Logistic EuroSCORE I ≥ 20 % , comorbidity judge heart team pose absolute relative contraindication conventional aortic valve replacement ; Age ≥ 18 year ; The patient inform nature study consent participate , authorize collection release his/her medical information sign consent form ( `` Patient Informed Consent Form '' ) . Patient understand implication participate study legally competent provide inform consent . Unicuspid bicuspid aortic valve ; Echocardiographic evidence intracardiac mass , thrombus , vegetation ; Left ventricular ejection fraction &lt; 25 % ; Left ventricular outflow obstruction , Hypertrophic Obstructive Cardiomyopathy severe septal hypertrophy ; Mitral tricuspid regurgitation great 2+ angiography moderate echocardiography ; Patients life expectancy le 12 month due underlying noncardiac comorbid disease ; Known hypersensitivity contraindication aspirin , heparin , ticlopidine , clopidogrel , Nitinol contrast medium adequately controlled premedication ; Sepsis acute endocarditis ; Blood dyscrasia acute anemia , leucopenia , thrombocytopenia ; bleed diathesis , coagulopathy ; Renal insufficiency assess creatinine clearance &lt; 20 ml/min and/or endstage renal disease require chronic dialysis ; Active peptic ulcer GI bleeding within 3 month plan index procedure ; Untreated clinically significant coronary artery disease require revascularization ; Cardiogenic shock , suspect cardiogenic shock , hemodynamic instability require inotropic support mechanical heart assistance ; Significant aortic disease , include abdominal thoracic aortic aneurysm , define maximal luminal diameter 5 cm great ; Need emergency surgery , cardiac noncardiac ; History myocardial infarction last 6 week ; History TIA CVA last 6 month ; Therapeutic invasive cardiac procedure , exception BAV , perform within 30 day plan date valve implantation , 6 month case drugeluting stent ; Preexisting prosthetic heart valve prosthetic ring position ; Patient refuse blood transfusion ; Patient currently enrol another investigational device drug trial may influence outcome trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>